Route of anticholinesterase contamination
| Enteral only (n=27) | Transcutaneous only (n=8) | p value | |
|---|---|---|---|
| Pseudocholinesterase (IU/l) | 495 (82–7404) | 180 (83–6200) | 0.17 |
| Total atropine dose (mg/kg) | 0.48 (0.09–1.30) | 0.20 (0.08–16.70) | 0.63 |
| Seizures (no.) (%) | 11 (41) | 2 (25) | 0.68 |
| Ventilation (no.) (%) | 13 (48) | 2 (25) | 0.42 |
| Cardiac arrhythmia (no.) (%) | 4 (15) | 0 (0) | 0.55 |
| Mortality (no.) (%) | 3 (11) | 0 (0) | 1.00 |
| Duration of ventilation (survivors) | 2 days (2–3) | 1 day (1–39) | 0.69 |
| Duration of ICU (survivors) | 4 days (2–9) | 2 days (1–83) | 0.15 |